XYRA, Announces

XYRA Announces FDA Label Guidance for Managing Atrial Fibrillation with Budiodarone and Wearable Monitoring Devices

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

XYRA United Kingdom England California

View original content:https://www.prnewswire.co.uk/news-releases/xyra-announces-fda-label-guidance-for-managing-atrial-fibrillation-with-budiodarone-and-wearable-monitoring-devices-302276953.html

en | boerse | 67985157 |